Cargando…
Correction: miR155, TREM2, INPP5D: Disease stage and cell-type are essential considerations when targeting clinical interventions based on mouse models of Alzheimer’s amyloidopathy
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10688142/ https://www.ncbi.nlm.nih.gov/pubmed/38037091 http://dx.doi.org/10.1186/s12974-023-02954-z |
| _version_ | 1785152121607290880 |
|---|---|
| author | Gandy, Sam Ehrlich, Michelle E. |
| author_facet | Gandy, Sam Ehrlich, Michelle E. |
| author_sort | Gandy, Sam |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10688142 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | BioMed Central |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-106881422023-11-30 Correction: miR155, TREM2, INPP5D: Disease stage and cell-type are essential considerations when targeting clinical interventions based on mouse models of Alzheimer’s amyloidopathy Gandy, Sam Ehrlich, Michelle E. J Neuroinflammation Correction BioMed Central 2023-11-30 /pmc/articles/PMC10688142/ /pubmed/38037091 http://dx.doi.org/10.1186/s12974-023-02954-z Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
| spellingShingle | Correction Gandy, Sam Ehrlich, Michelle E. Correction: miR155, TREM2, INPP5D: Disease stage and cell-type are essential considerations when targeting clinical interventions based on mouse models of Alzheimer’s amyloidopathy |
| title | Correction: miR155, TREM2, INPP5D: Disease stage and cell-type are essential considerations when targeting clinical interventions based on mouse models of Alzheimer’s amyloidopathy |
| title_full | Correction: miR155, TREM2, INPP5D: Disease stage and cell-type are essential considerations when targeting clinical interventions based on mouse models of Alzheimer’s amyloidopathy |
| title_fullStr | Correction: miR155, TREM2, INPP5D: Disease stage and cell-type are essential considerations when targeting clinical interventions based on mouse models of Alzheimer’s amyloidopathy |
| title_full_unstemmed | Correction: miR155, TREM2, INPP5D: Disease stage and cell-type are essential considerations when targeting clinical interventions based on mouse models of Alzheimer’s amyloidopathy |
| title_short | Correction: miR155, TREM2, INPP5D: Disease stage and cell-type are essential considerations when targeting clinical interventions based on mouse models of Alzheimer’s amyloidopathy |
| title_sort | correction: mir155, trem2, inpp5d: disease stage and cell-type are essential considerations when targeting clinical interventions based on mouse models of alzheimer’s amyloidopathy |
| topic | Correction |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10688142/ https://www.ncbi.nlm.nih.gov/pubmed/38037091 http://dx.doi.org/10.1186/s12974-023-02954-z |
| work_keys_str_mv | AT gandysam correctionmir155trem2inpp5ddiseasestageandcelltypeareessentialconsiderationswhentargetingclinicalinterventionsbasedonmousemodelsofalzheimersamyloidopathy AT ehrlichmichellee correctionmir155trem2inpp5ddiseasestageandcelltypeareessentialconsiderationswhentargetingclinicalinterventionsbasedonmousemodelsofalzheimersamyloidopathy |